News

(July 6, 2018) – Johns Hopkins researchers say they have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson’s disease itself — as well as its symptoms — in mice. The drug is expected t …

(July 5, 2018) – Sunovion will offer a Parkinson’s Educational Lunch Program on Wednesday, July 25, 2018 in Cherry Hill, NJ. Hear from someone living with PD, learn from an expert, share your knowledge, and pick up tips on how to manage the disease. Cl …

(July 5, 2018) – Isradipine, an antihypertensive drug, is emerging as a potential new treatment for Parkinson’s disease due to promising results of in vitro tests. Until now, it was unclear whether administering the drug in vivo would yield the same be …

(June 22, 2018) – Voyager Therapeutics announced that the US Food and Drug Administration granted regenerative medicine advanced therapy (RMAT) designation for VY-AADC gene therapy for treatment of Parkinson’s disease in patients with motor fluctuation …

(June 15, 2018) – Medtronic, the global leader in medical technology, today announced that the U.S. Food and Drug Administration (FDA) recently approved its state-of-the art Deep Brain Stimulation (DBS) Clinician Programmer and Activa(TM)Programming Ap …

(June 15, 2018) – The Apple Watch will soon be able to track tremors experienced by Parkinson’s Disease patients to help them manage their condition. Later this year, Apple will release a software update to make it easier for medical researchers to und …

(June 15, 2018) – The Nilotinib in Parkinson’s Disease Study is recruiting candidates for their clinical trial. Nilotinib is currently approved by the U.S. Food and Drug Administration to treat a cancer of the white blood cells. This study will evaluat …

(June 12, 2018) – Sunovion Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application for apomorphine sublingual film (APL-130277) to treat motor fluctuations experienced by people living …

(June 4, 2018) – A new and experimental deep brain stimulation (DBS) system uses feedback from the brain to fine-tune its signaling in response to signs of dyskinesia, potentially offering a more refined way to ease motor problems in Parkinson’s patien …

(May 30, 2018) – Dr. Jill Farmer, Assistant Professor of Neurology and Director, Parkinson’s Disease (PD) & Movement Disorders Program at Drexel University, held a free patient and care partner education program on April 27, 2018 in Lambertville, N …